FENC Fennec Pharmaceuticals Inc.Stock Price & Overview
$9.21
Charts
Quant Ranking
FENC Analysis
FENC News
Latest Headlines
Ratings Summary
People Also Follow
Similar to FENC
ETFs Holding FENC
FENC Company Profile
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
FENC Revenue
FENC Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
FENC Ownership
FENC Peers
Risk
Technicals
FENC Transcripts
Investor Presentations
FENC SEC Filings
Press Releases
FENC Income Statement
FENC Balance Sheet
FENC Cash Flow Statement
FENC Long Term Solvency
Discover More
You may be interested in: